Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide

Until today, the oral delivery of peptide drugs is hampered due to their instability in the gastrointestinal tract and low mucosal penetration. To overcome these hurdles, PLA (polylactide acid)-nanoparticles were coated with a cyclic, polyarginine-rich, cell penetrating peptide (cyclic R9-CPP). Thes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Uhl, Philipp (VerfasserIn) , Sauter, Max (VerfasserIn) , Storck, Philip (VerfasserIn) , Tursch, Anja (VerfasserIn) , Özbek, Suat (VerfasserIn) , Leotta, Karin (VerfasserIn) , Fidelj, Veronika (VerfasserIn) , Kleist, Christian (VerfasserIn) , Fricker, Gert (VerfasserIn) , Mier, Walter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2020
In: Nanomedicine. Nanotechnology, biology and medicine
Year: 2020, Jahrgang: 24
ISSN:1549-9642
DOI:10.1016/j.nano.2019.102132
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.nano.2019.102132
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1549963419302163
Volltext
Verfasserangaben:P. Uhl, PhD, C.Grundmann, M. Sauter, PhD, P. Storck, A. Tursch, S. Özbek, Prof, PhD, K. Leotta, R. Roth, PhD, D. Witzigmann, PhD, J.A. Kulkarnie, V. Fidelj, C. Kleist, PhD, P.R. Cullis, Prof, PhD, G. Fricker, Prof, PhD, W. Mier, Prof, PhD

MARC

LEADER 00000caa a22000002c 4500
001 1694852857
003 DE-627
005 20230427070537.0
007 cr uuu---uuuuu
008 200417s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.nano.2019.102132  |2 doi 
035 |a (DE-627)1694852857 
035 |a (DE-599)KXP1694852857 
035 |a (OCoLC)1341315573 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Uhl, Philipp  |e VerfasserIn  |0 (DE-588)1112349391  |0 (DE-627)866420797  |0 (DE-576)476575230  |4 aut 
245 1 0 |a Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide  |c P. Uhl, PhD, C.Grundmann, M. Sauter, PhD, P. Storck, A. Tursch, S. Özbek, Prof, PhD, K. Leotta, R. Roth, PhD, D. Witzigmann, PhD, J.A. Kulkarnie, V. Fidelj, C. Kleist, PhD, P.R. Cullis, Prof, PhD, G. Fricker, Prof, PhD, W. Mier, Prof, PhD 
264 1 |c 2020 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 27 November 2019 
500 |a Gesehen am 17.04.2020 
520 |a Until today, the oral delivery of peptide drugs is hampered due to their instability in the gastrointestinal tract and low mucosal penetration. To overcome these hurdles, PLA (polylactide acid)-nanoparticles were coated with a cyclic, polyarginine-rich, cell penetrating peptide (cyclic R9-CPP). These surface-modified nanoparticles showed a size and polydispersity index comparable to standard PLA-nanoparticles. The zeta potential showed a significant increase indicating successful CPP-coupling to the surface of the nanoparticles. Cryo-EM micrographs confirmed the appropriate size and morphology of the modified nanoparticles. A high encapsulation efficiency of liraglutide could be achieved. In vitro tests using Caco-2 cells showed high viability indicating the tolerability of this novel formulation. A strongly enhanced mucosal binding and penetration was demonstrated by a Caco-2 binding and uptake assay. In Wistar rats, the novel nanoparticles showed a substantial, 4.5-fold increase in the oral bioavailability of liraglutide revealing great potential for the oral delivery of peptide drugs. 
650 4 |a Cell penetrating peptides 
650 4 |a Liraglutide 
650 4 |a Nanoparticles 
650 4 |a Oral delivery 
650 4 |a Peptide drugs 
650 4 |a Polylactide acid 
700 1 |a Sauter, Max  |e VerfasserIn  |0 (DE-588)1103516507  |0 (DE-627)86126813X  |0 (DE-576)470642033  |4 aut 
700 1 |a Storck, Philip  |d 1993-  |e VerfasserIn  |0 (DE-588)1167955285  |0 (DE-627)1031648348  |0 (DE-576)511359721  |4 aut 
700 1 |a Tursch, Anja  |d 1989-  |e VerfasserIn  |0 (DE-588)1111529523  |0 (DE-627)865936196  |0 (DE-576)476147301  |4 aut 
700 1 |a Özbek, Suat  |d 1968-  |e VerfasserIn  |0 (DE-588)122090470  |0 (DE-627)70576852X  |0 (DE-576)293087024  |4 aut 
700 1 |a Leotta, Karin  |e VerfasserIn  |0 (DE-588)1068657669  |0 (DE-627)82057404X  |0 (DE-576)427989345  |4 aut 
700 1 |a Fidelj, Veronika  |d 1987-  |e VerfasserIn  |0 (DE-588)1208775839  |0 (DE-627)1695612051  |4 aut 
700 1 |a Kleist, Christian  |e VerfasserIn  |0 (DE-588)138977410  |0 (DE-627)703170287  |0 (DE-576)309272971  |4 aut 
700 1 |a Fricker, Gert  |d 1956-  |e VerfasserIn  |0 (DE-588)1042227675  |0 (DE-627)768469465  |0 (DE-576)393783464  |4 aut 
700 1 |a Mier, Walter  |d 1966-  |e VerfasserIn  |0 (DE-588)12029026X  |0 (DE-627)69653567X  |0 (DE-576)292141599  |4 aut 
773 0 8 |i Enthalten in  |t Nanomedicine. Nanotechnology, biology and medicine  |d New York, NY : Elsevier, 2005  |g 24(2020) Artikel-Nummer 102132, 10 Seiten  |h Online-Ressource  |w (DE-627)483610917  |w (DE-600)2183417-9  |w (DE-576)25948654X  |x 1549-9642  |7 nnas  |a Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide 
773 1 8 |g volume:24  |g year:2020  |g extent:10  |a Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide 
856 4 0 |u https://doi.org/10.1016/j.nano.2019.102132  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1549963419302163  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200417 
993 |a Article 
994 |a 2010 
998 |g 1208775839  |a Fidelj, Veronika  |m 1208775839:Fidelj, Veronika  |d 160000  |d 160100  |e 160000PF1208775839  |e 160100PF1208775839  |k 0/160000/  |k 1/160000/160100/  |p 11 
998 |g 1167955285  |a Storck, Philip  |m 1167955285:Storck, Philip  |d 910000  |d 911400  |e 910000PS1167955285  |e 911400PS1167955285  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 12029026X  |a Mier, Walter  |m 12029026X:Mier, Walter  |d 910000  |d 911400  |e 910000PM12029026X  |e 911400PM12029026X  |k 0/910000/  |k 1/910000/911400/  |p 15  |y j 
998 |g 1042227675  |a Fricker, Gert  |m 1042227675:Fricker, Gert  |d 160000  |d 160100  |e 160000PF1042227675  |e 160100PF1042227675  |k 0/160000/  |k 1/160000/160100/  |p 14 
998 |g 138977410  |a Kleist, Christian  |m 138977410:Kleist, Christian  |d 910000  |d 911400  |e 910000PK138977410  |e 911400PK138977410  |k 0/910000/  |k 1/910000/911400/  |p 12 
998 |g 1068657669  |a Leotta, Karin  |m 1068657669:Leotta, Karin  |p 7 
998 |g 122090470  |a Özbek, Suat  |m 122090470:Özbek, Suat  |d 700000  |d 721000  |e 700000PO122090470  |e 721000PO122090470  |k 0/700000/  |k 1/700000/721000/  |p 6 
998 |g 1111529523  |a Tursch, Anja  |m 1111529523:Tursch, Anja  |d 700000  |d 721000  |e 700000PT1111529523  |e 721000PT1111529523  |k 0/700000/  |k 1/700000/721000/  |p 5 
998 |g 1103516507  |a Sauter, Max  |m 1103516507:Sauter, Max  |d 910000  |d 910100  |e 910000PS1103516507  |e 910100PS1103516507  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1112349391  |a Uhl, Philipp  |m 1112349391:Uhl, Philipp  |d 910000  |d 911400  |e 910000PU1112349391  |e 911400PU1112349391  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1694852857  |e 362477302X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide","title":"Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide"}],"person":[{"display":"Uhl, Philipp","role":"aut","given":"Philipp","family":"Uhl"},{"family":"Sauter","display":"Sauter, Max","role":"aut","given":"Max"},{"family":"Storck","given":"Philip","role":"aut","display":"Storck, Philip"},{"display":"Tursch, Anja","role":"aut","given":"Anja","family":"Tursch"},{"family":"Özbek","display":"Özbek, Suat","given":"Suat","role":"aut"},{"given":"Karin","role":"aut","display":"Leotta, Karin","family":"Leotta"},{"display":"Fidelj, Veronika","role":"aut","given":"Veronika","family":"Fidelj"},{"family":"Kleist","display":"Kleist, Christian","role":"aut","given":"Christian"},{"family":"Fricker","display":"Fricker, Gert","role":"aut","given":"Gert"},{"display":"Mier, Walter","role":"aut","given":"Walter","family":"Mier"}],"name":{"displayForm":["P. Uhl, PhD, C.Grundmann, M. Sauter, PhD, P. Storck, A. Tursch, S. Özbek, Prof, PhD, K. Leotta, R. Roth, PhD, D. Witzigmann, PhD, J.A. Kulkarnie, V. Fidelj, C. Kleist, PhD, P.R. Cullis, Prof, PhD, G. Fricker, Prof, PhD, W. Mier, Prof, PhD"]},"note":["Available online 27 November 2019","Gesehen am 17.04.2020"],"relHost":[{"titleAlt":[{"title":"Nanomedicine / Nanotechnology, biology and medicine"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisher":"Elsevier","dateIssuedDisp":"2005-","dateIssuedKey":"2005","publisherPlace":"New York, NY"}],"recId":"483610917","physDesc":[{"extent":"Online-Ressource"}],"disp":"Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutideNanomedicine. Nanotechnology, biology and medicine","id":{"eki":["483610917"],"issn":["1549-9642"],"zdb":["2183417-9"]},"note":["Gesehen am 04.02.2021","Fortsetzung der Druck-Ausgabe"],"name":{"displayForm":["American Academy of Nanomedicine"]},"pubHistory":["1.2005 -"],"title":[{"title_sort":"Nanomedicine","title":"Nanomedicine","partname":"Nanotechnology, biology and medicine"}],"language":["eng"],"part":{"extent":"10","text":"24(2020) Artikel-Nummer 102132, 10 Seiten","year":"2020","volume":"24"}}],"id":{"doi":["10.1016/j.nano.2019.102132"],"eki":["1694852857"]},"physDesc":[{"extent":"10 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2020","dateIssuedKey":"2020"}],"recId":"1694852857"} 
SRT |a UHLPHILIPPCOATINGOFP2020